Anxiety & Depression in Thyroid Cancer Patients

NCT06269731 | Not Yet Recruiting

• 1 other identifier: Thyroid cancer
• Study Type: observational
• Target: 159
• Locations: 0 countries
• Sites: N/A

Brief Summary

1. 1.To identify the prevalence of both anxiety and depression in thyroid cancer patients
2. 2.To assess quality of life in thyroid cancer patients

Conditions

Thyroid Cancer

Keywords

depression; anxiety

Outcome Measures

Primary Outcomes (2)

• the prevalence of anxiety in thyroid cancer patients

  To identify the prevalence of anxiety in thyroid cancer patients by using Hamilton Anxiety Rating Scale

  baseline

• the prevalence of depression in thyroid cancer patients

  To identify the prevalence of depression in thyroid cancer patients by using Hamilton Depression Rating Scale

  baseline

Secondary Outcomes (1)

• assess quality of life in thyroid cancer patients

  baseline

Interventions

Hamilton depression Rating Scale BEHAVIORAL

also known as the Ham-D is the most widely used clinician-administered depression assessment scale. The original version contains 17 items (HDRS17) pertaining to symptoms of depression experienced over the past week. Although the scale was designed for completion after an unstructured clinical interview, The scale has been translated into a number of languages including French, German, Italian, Thai , Turkish and Arabic version by Mostafa Lotfy.

Also known as: Hamilton Anxiety Rating Scale, Quality of life Questionnaire, Symptom Checklist-90-Revised

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

thyroid cancer patients

You may qualify if:

• Age at or more than 18 years old
• None of the patients had history of other psychiatric illness
• Both sex
• Accept to participate in the study

You may not qualify if:

• Age less than 18 years old
• Previous history of other psychiatric illness
• substance abuser or dependence
• Refuse to participate in the study

Sponsors & Collaborators

• Assiut University: lead

Related Publications (3)

• Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W, Gorges R. Health-related Quality of Life, depression and anxiety in thyroid cancer patients. Qual Life Res. 2006 May;15(4):695-703. doi: 10.1007/s11136-005-3689-7.

  PMID: 16688502 BACKGROUND

• Dionisi-Vici M, Fantoni M, Botto R, Nervo A, Felicetti F, Rossetto R, Gallo M, Arvat E, Torta R, Leombruni P. Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study. Endocrine. 2021 Dec;74(3):603-610. doi: 10.1007/s12020-021-02786-y. Epub 2021 Jun 18.

  PMID: 34143334 BACKGROUND

• Alexander K, Lee SC, Georgiades S, Constantinou C. The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life. J Med Life. 2023 Mar;16(3):348-371. doi: 10.25122/jml-2022-0204.

  PMID: 37168306 BACKGROUND

MeSH Terms

Conditions

Thyroid Neoplasms; Depression; Anxiety Disorders

Condition Hierarchy (Ancestors)

Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Head and Neck Neoplasms; Endocrine System Diseases; Thyroid Diseases; Behavioral Symptoms; Behavior; Mental Disorders

Central Study Contacts

salma mamdouh

CONTACT

+201016297915; salmamamdouhmm@gmail.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: doctor

Study Record Dates

• First Submitted: February 6, 2024
• First Posted: February 21, 2024
• Study Start: March 1, 2024
• Primary Completion: December 1, 2025
• Study Completion: March 1, 2026
• Last Updated: February 21, 2024

Record last verified: 2024-02